Senior Director Global Regulatory Lead (Early Phase) - Oncology
Eli Lilly and CompanySalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Biotechnology, HealthcareIndustries
Requirements
Candidates should possess a Bachelor’s degree and 12+ years of professional and scientific experience, or a Master’s degree with 10+ years of scientific experience, or a PhD/PharmD/DVM/MD or similar life sciences education with 5-8+ years of scientific experience in the biotech or pharmaceutical industry. Prior experience in Corporate Development is preferred.
Responsibilities
The Director, Corporate Development will proactively identify and evaluate external opportunities aligned with Gilead’s R&D Oncology and Inflammation strategies, working directly with the Search and Evaluation team and Competitive Intelligence group. They will present opportunity summaries and recommendations to leadership, lead cross-functional scientific diligence teams, summarize key findings and risks, prepare presentations for Gilead’s internal Governance body, and partner with Corporate Development Business leads to define structure and terms for proposals. The role also offers the opportunity to learn about partnering and acquisitions.
Skills
Corporate Development
Due Diligence
Scientific Strategy
Partnering
Acquisitions
Presentation Skills
Cross-functional Collaboration
Risk Assessment
Gilead Sciences
Develops and commercializes biopharmaceuticals
About Gilead Sciences
Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.
Key Metrics
Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees